Cistplatinum (CDDP) - interleukin 2 (IL2) -Alpha-interferon (oc-IFN) chemoimmunotherapy of metastatic malignant melanoma

Melanoma Research ◽

10.1097/00008390-199303000-00175 ◽

1993 ◽

Vol 3 (1) ◽

pp. 50

Author(s):

E. Vuillemin ◽

Ch. Borel ◽

R. Mouawad ◽

A. Benhammouda ◽

A. Thomas ◽

...

Keyword(s):

Malignant Melanoma ◽

Interleukin 2 ◽

Metastatic Malignant Melanoma ◽

Alpha Interferon

Download Full-text

Tamoxifen (TMX), cisplatinum (CDDP), interleukin 2 (IL2) and alpha-interferon (αlFN) combination in the treatment of metastatic malignant melanoma (MMM)

Melanoma Research ◽

10.1097/00008390-199303000-00176 ◽

1993 ◽

Vol 3 (1) ◽

pp. 51

Author(s):

D. Khayat ◽

Ch. Borel ◽

A. Benhammouda ◽

E. Vuillemin ◽

E. Mularoni ◽

...

Keyword(s):

Malignant Melanoma ◽

Interleukin 2 ◽

Metastatic Malignant Melanoma ◽

Alpha Interferon

Download Full-text

Subcutaneous interleukin-2 and interferon-α plus cisplatin with and without prophylactic cimetidine in patients with metastatic malignant melanoma: a phase II study

Melanoma Research ◽

10.1097/00008390-200002000-00009 ◽

2000 ◽

Vol 10 (1) ◽

pp. 66-77

Author(s):

H. Schmidt ◽

P. F. Geertsen ◽

K. Fode ◽

C. Rytter ◽

L. Bastholt ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Interleukin 2 ◽

Metastatic Malignant Melanoma ◽

Download Full-text

Low-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanoma

Journal of Experimental Therapeutics and Oncology ◽

10.1046/j.1359-4117.2003.01093.x ◽

2003 ◽

Vol 3 (4) ◽

pp. 161-168 ◽

Author(s):

Akmal Safwat ◽

Ninna Aggerholm ◽

Ivan Roitt ◽

Jens Overgaard ◽

Marianne Hokland

Keyword(s):

Malignant Melanoma ◽

Mouse Model ◽

Therapeutic Effect ◽

Total Body Irradiation ◽

Low Dose ◽

Interleukin 2 ◽

Metastatic Malignant Melanoma ◽

Download Full-text

Subcutaneous interleukin-2 and interferon-α plus cisplatin with and without prophylactic cimetidine in patients with metastatic malignant melanoma: a phase II study

Melanoma Research ◽

10.1097/00008390-200010010-00009 ◽

2000 ◽

Vol 10 (1) ◽

pp. 66-77 ◽

Author(s):

H. Schmidt ◽

P. F. Geertsen ◽

K. Fode ◽

C. Rytter ◽

L. Bastholt ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Interleukin 2 ◽

Metastatic Malignant Melanoma ◽

Download Full-text

Phase I—II with repeated tumor infiltrating lymphocytes (TIL) infusion, without or with interleukin-2 (IL-2) in metastatic malignant melanoma (MMM)

Melanoma Research ◽

10.1097/00008390-199303000-00288 ◽

1993 ◽

Vol 3 (1) ◽

pp. 78

Author(s):

A. Ravaud ◽

E. Legrand ◽

M. Delaunay ◽

E. Bussières ◽

B. N. Bui ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase I ◽

Interleukin 2 ◽

Tumor Infiltrating Lymphocytes ◽

Metastatic Malignant Melanoma ◽

Infiltrating Lymphocytes

Download Full-text

A Low Rate of Central Nervous System Progression in a Phase II Trial of Outpatient Chemobiologic Therapy With Cisplatin, Temozolomide, Interleukin-2, and Interferon Alfa 2-B for Metastatic Malignant Melanoma

American Journal of Clinical Oncology ◽

10.1097/01.coc.0000164006.72694.1b ◽

2005 ◽

Vol 28 (5) ◽

pp. 479-484 ◽

Author(s):

Neal Ready ◽

Frederick Aronson ◽

Harold Wanebo ◽

Theresa Kennedy

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Interleukin 2 ◽

Metastatic Malignant Melanoma ◽

Interferon Alfa ◽

Download Full-text

Review of interleukin-2 alone and interleukin-2/LAK clinical trials in metastatic malignant melanoma

Cancer Treatment Reviews ◽

10.1016/0305-7372(89)90020-0 ◽

1989 ◽

Vol 16 ◽

pp. 29-38 ◽

Author(s):

Mario Sznol ◽

Janice P. Dutcher ◽

Michael B. Atkins ◽

Anthony R.A. Rayner ◽

Kim A. Margolin ◽

...

Keyword(s):

Clinical Trials ◽

Malignant Melanoma ◽

Interleukin 2 ◽

Metastatic Malignant Melanoma

Download Full-text

A randomized phase II trial of SRL172 (Mycobacterium vaccae) ± low-dose interleukin-2 in the treatment of metastatic malignant melanoma

Melanoma Research ◽

10.1097/00008390-200308000-00008 ◽

2003 ◽

Vol 13 (4) ◽

pp. 389-393 ◽

Author(s):

S Nicholson ◽

K Guile ◽

J John ◽

I A Clarke ◽

J Diffley ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Trial ◽

Interleukin 2 ◽

Metastatic Malignant Melanoma ◽

Mycobacterium Vaccae ◽

Randomized Phase Ii

Download Full-text

Treatment with histamine dihydrochloride and interleukin-2 in patients with advanced metastatic malignant melanoma

Melanoma Research ◽

10.1097/00008390-200306000-00014 ◽

2003 ◽

Vol 13 (3) ◽

pp. 307-311 ◽

Author(s):

Steven J O'Day ◽

Sanjiv S Agarwala ◽

Peter Naredi ◽

Carrie L Kass ◽

Kurt R Gehlsen ◽

...

Keyword(s):

Malignant Melanoma ◽

Interleukin 2 ◽

Metastatic Malignant Melanoma ◽

Histamine Dihydrochloride

Download Full-text

Outpatient Experience With Moderate Dose Bolus Interleukin-2 in Metastatic Malignant Melanoma and Kidney Cancer

Journal of Immunotherapy ◽

10.1097/00002371-200305000-00012 ◽

2003 ◽

Vol 26 (3) ◽

pp. 286-290 ◽

Author(s):

Walter D. Y. Quan, ◽

Francine M. Quan

Keyword(s):

Malignant Melanoma ◽

Kidney Cancer ◽

Interleukin 2 ◽

Metastatic Malignant Melanoma ◽

Download Full-text